Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept

BACKGROUND: Melanocortin receptor (MCR) agonists have anti-inflammatory and immunomodulatory properties mediated by receptors expressed on cells relevant to arthritis. Repository corticotropin injection (RCI; Acthar® Gel), an MCR agonist preparation, is approved as adjunctive therapy for rheumatoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Decker, Dima A., Higgins, Paul, Hayes, Kyle, Bollinger, Chris, Becker, Patrice, Wright, Dale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460755/
https://www.ncbi.nlm.nih.gov/pubmed/32867752
http://dx.doi.org/10.1186/s12891-020-03609-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460755/
https://www.ncbi.nlm.nih.gov/pubmed/32867752
http://dx.doi.org/10.1186/s12891-020-03609-3

Ejemplares similares